1. Home
  2. CTSO vs MOB Comparison

CTSO vs MOB Comparison

Compare CTSO & MOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • MOB
  • Stock Information
  • Founded
  • CTSO 1997
  • MOB 2008
  • Country
  • CTSO United States
  • MOB Israel
  • Employees
  • CTSO N/A
  • MOB N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • MOB Real Estate Investment Trusts
  • Sector
  • CTSO Health Care
  • MOB Real Estate
  • Exchange
  • CTSO Nasdaq
  • MOB Nasdaq
  • Market Cap
  • CTSO 61.7M
  • MOB 53.1M
  • IPO Year
  • CTSO N/A
  • MOB 2022
  • Fundamental
  • Price
  • CTSO $1.00
  • MOB $6.27
  • Analyst Decision
  • CTSO Buy
  • MOB Strong Buy
  • Analyst Count
  • CTSO 2
  • MOB 1
  • Target Price
  • CTSO $5.50
  • MOB $10.00
  • AVG Volume (30 Days)
  • CTSO 123.9K
  • MOB 521.3K
  • Earning Date
  • CTSO 11-06-2025
  • MOB 08-12-2025
  • Dividend Yield
  • CTSO N/A
  • MOB N/A
  • EPS Growth
  • CTSO N/A
  • MOB N/A
  • EPS
  • CTSO N/A
  • MOB N/A
  • Revenue
  • CTSO $36,107,520.00
  • MOB $2,826,361.00
  • Revenue This Year
  • CTSO $11.93
  • MOB N/A
  • Revenue Next Year
  • CTSO $21.22
  • MOB N/A
  • P/E Ratio
  • CTSO N/A
  • MOB N/A
  • Revenue Growth
  • CTSO 20.18
  • MOB N/A
  • 52 Week Low
  • CTSO $0.71
  • MOB $0.85
  • 52 Week High
  • CTSO $1.61
  • MOB $6.75
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 52.14
  • MOB 66.95
  • Support Level
  • CTSO $0.94
  • MOB $5.30
  • Resistance Level
  • CTSO $0.99
  • MOB $6.75
  • Average True Range (ATR)
  • CTSO 0.07
  • MOB 0.69
  • MACD
  • CTSO 0.01
  • MOB 0.08
  • Stochastic Oscillator
  • CTSO 82.21
  • MOB 84.66

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About MOB Mobilicom Limited

Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.

Share on Social Networks: